FDA Clearance Tracker · P990027-S012
BAUSCH & LOMB TECHNOLAS 217Z ZYOPTIX SYSTEM FOR PERSONALIZED VISION CORRECTION
Last checked: Nov 20, 2026Latest source record: Jun 26, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Jun 26, 2009
Approved
Time to decision
42 days
Received May 15, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P990027-S012
- Device name
- BAUSCH & LOMB TECHNOLAS 217Z ZYOPTIX SYSTEM FOR PERSONALIZED VISION CORRECTION
- Applicant
- Technolas Perfect Vision GmbH
- Applicant location
- MüNchen
- Received
- May 15, 2009
- Decided
- Jun 26, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P990027
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE CHANGE LOCATED AT TECHNOLAS PERFECTVISION GMBH, MUNICH, GERMANY.
Source documents
Other decisions for Technolas Perfect Vision GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TECHNOLAS TENEO 317 (MODEL 2) Excimer Laser SystemPMA supplement
P990027-S021 · Decided Nov 22, 2023 · 293 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.